BSECompany Update▲ PositiveM&A28 Jul 2026
5paisa Capital Ltd
1. Approved the acquisition of 100% of the equity share capital of Giskard Datatech Private Limited ('Giskard' or 'Target Company') through a combination of cash consideration and a share ....
5paisa Capital Ltd has approved the acquisition of 100% of Giskard Datatech Private Limited through a combination of cash consideration and a share swap arrangement, and also approved a preferential issue of 20,50,588 equity shares of 5paisa Capital Ltd in lieu of acquiring shares of Giskard.
NSEPreferential issue▲ PositiveFundraise28 Jul 2026
5Paisa Capital Limited
Preferential issue
5Paisa Capital Limited has informed the Exchange about a preferential issue of 20,50,588 equity shares by consideration other than cash, in lieu of acquiring shares of Giskard Datatech Private Limited, as part of its strategic growth initiatives.
BSECompany Update▲ PositiveM&A28 Jul 2026
5paisa Capital Ltd
Approved the acquisition of 100% of the equity share capital of Giskard Datatech Private Limited ('Giskard' or 'Target Company') through a combination of cash consideration and a share ....
5paisa Capital Ltd approved the acquisition of 100% of the equity share capital of Giskard Datatech Private Limited through a combination of cash consideration and a share swap arrangement. The acquisition will enable the integration of Target Company advanced research and analytics capabilities into the Company's platform.
BSEBoard Meeting▲ PositiveM&A28 Jul 2026
5paisa Capital Ltd
In furtherance of the prior Intimation given to the stock exchanges on July 23, 2026, and in terms of Regulation 30 of the SEBI (LODR) Regulations, 2015 ('SEBI Listing Regulations'), we ....
5paisa Capital Ltd has approved the acquisition of 100% of the equity share capital of Giskard Datatech Private Ltd through a combination of cash consideration and a share swap arrangement. The acquisition will enable the integration of Giskard's advanced research and analytics capabilities into 5paisa's platform, enhancing the overall customer experience.
NSEOutcome of Board Meeting▲ PositiveM&A28 Jul 2026
5Paisa Capital Limited
Outcome of Board Meeting
5Paisa Capital Limited has informed the Exchange regarding Outcome of Board Meeting held on July 28, 2026. The Board approved the acquisition of 100% of the equity share capital of Giskard Datatech Private Limited through a combination of cash consideration and a share swap arrangement. The Company proposes to acquire up to 1,03,082 equity shares of Giskard for an aggregate cash consideration not exceeding Rs. 1,21,57,49,108 and up to 66,148 equity shares through issuance of equity shares of the Company on a preferential basis.
NSEOutcome of Board Meeting▲ PositiveM&A28 Jul 2026
5Paisa Capital Limited
Outcome of Board Meeting
5Paisa Capital Limited has informed the Exchange regarding Outcome of Board Meeting held on July 28, 2026. The Board of Directors approved the acquisition of 100% of the equity share capital of Giskard Datatech Private Limited through a combination of cash consideration and a share swap arrangement. The Company proposes to acquire up to 1,03,082 equity shares of the Target Company for an aggregate cash consideration not exceeding Rs. 1,21,57,49,108.
BSEOthers▲ PositiveResults28 Jul 2026
Varroc Engineering Ltd
Annual Report
Varroc Engineering Ltd has released its Annual Report 2025-26, highlighting a year of defining progress with revenue of ₹88,905 Mn, EBITDA margin of 24.2%, and ROCE of 0.27x. The company has expanded its global R&D centres, patent filings, and manufacturing facilities, with a strong focus on sustainability and renewable energy. Key highlights include a 9.4% increase in revenue, a 4.3% increase in EBITDA margin, and a 37% increase in PBT margin.
NSEPress Release▲ PositiveProduct Launch28 Jul 2026
Glenmark Pharmaceuticals Limited
Press Release
Glenmark Pharmaceuticals Limited has announced the launch of Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials in the US market, which is expected to generate significant revenue.
BSECompany Update▲ PositiveProduct Launch28 Jul 2026
Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials
Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, with annual sales of approximately $1.6 billion in the 12-month period ending May 2026.
BSECompany Update▲ PositiveOrder Win28 Jul 2026
IRIS RegTech Solutions Ltd
We hereby submit an update on bagging of international order.
IRIS RegTech Solutions Ltd has received formal confirmation from Xpert Decisions Systems (Pty) Ltd regarding the extension of their existing engagement for Phase 4 of CODI deposit insurance solution.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults28 Jul 2026
Smartworks Coworking Spaces Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Smartworks Coworking Spaces Limited has announced its Q1 FY27 earnings, with revenues at INR 546 crores, up 44% year-on-year and 5% quarter-on-quarter, and normalized EBITDA of INR 107 crores, up 74% year-on-year and 8% quarter-on-quarter.
BSECompany Update▲ PositiveResults28 Jul 2026
Smartworks Coworking Spaces Ltd
Disclosure under Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015- Transcript
Smartworks Coworking Spaces Ltd reported Q1 FY27 results with revenue of INR 546 crores, up 44% YoY and 5% QoQ, and normalized EBITDA of INR 107 crores, up 74% YoY and 8% QoQ, with EBITDA margin expanding to 19.6%.
BSECompany Update▲ PositiveResults28 Jul 2026
Trualt Bioenergy Ltd
Please find attached the intimation
TruAlt Bioenergy Limited announced a strong Q1 FY27 performance, with total income nearly doubling and PAT rising over 12x due to the successful integration of the dual-feed ethanol platform and the continued execution of its integrated bioenergy strategy.
BSECompany Update▲ PositiveResults28 Jul 2026
NRB Bearings Ltd
Voluntary submission of the managing director''s speech for the 61st Annual General Meeting of the company scheduled to be held on Wednesday, July 29, 2026.
NRB Bearings Ltd has voluntarily submitted the Managing Director's speech for the 61st Annual General Meeting, highlighting the company's strong financial and operational performance in FY26, with a 77% rise in Profit After Tax and a 19% increase in EBITDA.
NSEUpdates▲ PositiveResults28 Jul 2026
NRB Bearing Limited
Updates
NRB Bearing Limited has voluntarily submitted the Managing Director's speech for the 61st Annual General Meeting, highlighting the company's strong financial and operational performance in FY26, with a 77% rise in Profit After Tax and 19% increase in EBITDA. The company is expanding its addressable market across six vital vectors, including aerospace, automotive adjacencies, and mobility beyond vehicles.
NSEPress Release▲ PositiveResults28 Jul 2026
TruAlt Bioenergy Limited
Press Release
TruAlt Bioenergy Limited announced a strong Q1 FY27 performance, with total income nearly doubling and PAT rising over 12x due to the successful integration of its dual-feed ethanol platform.
BSEOthers▲ PositiveResults28 Jul 2026
Restaurant Brands Asia Ltd
Annual Report 2025-26 of Restaurant Brands Asia Limited
Restaurant Brands Asia Ltd has released its Annual Report 2025-26, highlighting a year of gaining momentum with improved restaurant economics, expanding profitability, and a stronger balance sheet.
BSECompany Update▲ PositiveResults28 Jul 2026
Century Enka Ltd
Earnings Conference Call Presentation - Q1 FY27 attached.
Century Enka Ltd has released its Q1 FY27 earnings presentation, highlighting a 38.1% YoY increase in revenue from operations to INR 5,543 Mn, driven by robust demand for NTCF and higher share of better-margin products. EBITDA margins expanded to 15.46% from 4.96% YoY, while PAT margins rose to 11.13% from 3.84% YoY. The company expects demand fundamentals to remain healthy, but notes evolving geopolitical developments and inflation may impact demand in the coming quarters.
NSECopy of Newspaper Publication▲ PositiveResults28 Jul 2026
Canara Bank
Copy of Newspaper Publication
Canara Bank has published its unaudited financial results for the first quarter of 2026, showing a total income of ₹39,684.26 crore and a net profit of ₹6,555.82 crore.
BSECompany Update▲ PositiveMgmt Change28 Jul 2026
Infosys Ltd
Enclosed
Infosys Ltd announced the appointment of Ashiss Dash as the new CEO, effective April 1, 2027, to succeed Salil Parekh. The company also reported its Q1 FY 2026-27 financial results, with revenue growth of 2.4% Y-o-Y and 1% Q-o-Q in constant currency terms.